Zobrazeno 1 - 10
of 1 845
pro vyhledávání: '"fibrolamellar"'
Autor:
Othaim, Ayoub Al1 (AUTHOR) ay.alothaim@mu.edu.sa, Alasiri, Glowi2 (AUTHOR) gaalasiri@imamu.edu.sa, Alfahed, Abdulaziz3 (AUTHOR) a.alfahed@psau.edu.sa
Publikováno v:
Pharmaceuticals (14248247). Oct2024, Vol. 17 Issue 10, p1263. 19p.
Publikováno v:
Digestive Diseases & Sciences. Sep2024, Vol. 69 Issue 9, p3563-3573. 11p.
Autor:
Kundakcioglu, Hacer1 hacer.kundakcioglu@hotmail.com, Destek, Sabahattin2, Gucin, Zuhal3, Değer, Kamuran Cumhur1
Publikováno v:
Gastroenterology Review / Przegląd Gastroenterologiczny. 2022, Vol. 17 Issue 4, p344-347. 4p.
Autor:
Schoenfeld, Jonathan D1 (AUTHOR) jdschoenfeld@partners.org, Haas-Kogan, Daphne A2 (AUTHOR), O'Neill, Allison F3 (AUTHOR)
Publikováno v:
Lancet. 12/21/2024, Vol. 404 Issue 10471, p2603-2604. 2p.
Autor:
Amani, Marzieh1 (AUTHOR), Bavali, Ali1 (AUTHOR) alibavali@aut.ac.ir, Parvin, Parviz1 (AUTHOR)
Publikováno v:
Scientific Reports. 4/12/2022, Vol. 12 Issue 1, p1-10. 10p.
Autor:
AL Zahrani, Ali1 (AUTHOR) almaalzahrani@kfmc.med.sa, Alfakeeh, Ali1 (AUTHOR)
Publikováno v:
Journal of Medical Case Reports. 3/16/2021, Vol. 15 Issue 1, p1-5. 5p.
Autor:
Samuele Nicotra, Luca Melan, Alberto Busetto, Alessandro Bonis, Luigi Lione, Vincenzo Verzeletti, Federica Pezzuto, Andrea Dell’Amore, Fiorella Calabrese, Federico Rea
Publikováno v:
Livers, Vol 4, Iss 3, Pp 398-405 (2024)
Fibrolamellar hepatocellular carcinoma (FL-HCC) is a malignant primary hepatic cancer that affects mainly adolescents and young adults without underlying liver disease. Its biology remains unknown, but it is pathologically distinct from traditional H
Externí odkaz:
https://doaj.org/article/f37ddc9ce7674f9c8bd346f64d97fea8
Autor:
Ghassan K. Abou-Alfa, Tim Meyer, Richard Kinh Gian Do, Sarina A. Piha-Paul, Joseph S. Light, Scott Sherrin, Amin Yaqubie, Alison Clemens O’Neill, James J. Harding, Raed Al-Rajabi, Crystal S. Denlinger, Pablo Cano, Albert S. Cornelius, Eileen M. O'Reilly, Daniel DiPrimeo, Lisa D. Eli, John D. Gordan, David B. Solit
Publikováno v:
Liver Cancer, Pp 1-10 (2024)
Introduction: Fibrolamellar carcinoma (FLC) displays upregulation of several oncogenes, including HER2, and multiple immune-suppressive mechanisms. We investigated the efficacy and safety of the pan-HER tyrosine kinase inhibitor neratinib as monother
Externí odkaz:
https://doaj.org/article/060277f2d7054affa161c9c60698ca95
Autor:
Atiq, Muhammad1, Haroon, Muhammad1, Khan, Muhammad Imran1, Ammar, Ahmed Siddique1 Asammar1912@gmail.com, Khalid, Warda1, Hanif, Faisal1
Publikováno v:
Annals of King Edward Medical University. Apr-Jun2022, Vol. 28 Issue 2, p213-215. 3p.
Autor:
Jeong-Seon Lee1, Hye Young Jin2, Jung Min Ko1, Seoung Hoon Kim3, Nayoung Han4, Byung Kiu Park2, Meerim Park2, Hyeon Jin Park2, Jun Ah Lee2 junahlee@ncc.re.kr
Publikováno v:
Cancer Research & Treatment. Jan2021, Vol. 53 Issue 1, p283-288. 6p.